GlassScriptPhysician profile
Pasha Mostofi
NPI 1356743397
$3,773.98
in general payments reported to CMS, 2019-2025
13 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $437 · 2020: $241 · 2021: $839 · 2022: $243 · 2023: $1,659 · 2024: $64.70 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,242 · Travel and Lodging: $672 · Education: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,242.30 |
| Travel and Lodging | $672.00 |
| Education | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,099.38 | 2019-2023 | Vsp System, Vsp Cranial |
| Merz North America, INC. | $890.20 | 2021-2025 | Xeomin |
| Medical Device Business Services, INC. | $822.94 | 2023 | |
| Kls-Martin L.P. | $225.43 | 2021-2023 | |
| Straumann USA LLC | $176.62 | 2024-2025 | |
| Allergan, INC. | $131.07 | 2022 | |
| Abbvie INC. | $103.90 | 2023 | |
| Depuy Synthes Sales INC. | $97.35 | 2021 | |
| Mentor Worldwide LLC | $97.24 | 2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Pacira Pharmaceuticals Incorporated | $44.50 | 2021 | |
| Baxter Healthcare | $44.14 | 2023 | Artiss |
| Philips North America LLC | $22.91 | 2022 | |
| Zimvie INC. | $18.30 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pasha Mostofi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.